Home Online Features Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Hand-out
Press Releases
March 6, 2025

Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States

By Biocon Biologics Ltd.

BRIDGEWATER, N.J. and PETERSBURG, Va. and BENGALURU, India, March 6, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code:

bradford

The Bradford Era

email
Local & Social